Epanolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263121This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H23N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KGC55KP6A, chemically known as benzeneacetamide, n-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-4-hydroxy- but generally known as epanolol, which bears US NIH Compound Identifier 72014. European Medicines Agency schedules Epanolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06558MIG. The term EPANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules epanolol in its Anatomical Therapeutic Chemical (ATC) Classification. EPANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epanolol under HS 29269095 and SITC 51484. As of Q4 2014, EPANOLOL remains the US FDA Preferred Term for this commodity. Epanolol bears US NLM identifiers UMLS ID C0116294 and NCI Concept Code C72616. SMILES: OC(CNCCNC(=O)CC1CCC(O)CC1)COC1C(CCCC1)C#N.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.